Page 7 of 19 · 436 questions tagged vendor-vetting.
The case in front of me: TFC · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one.…
What I have: sampling plan · FGP. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Concretely: list of related substances · MKM. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: survodutide · date of analysis. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers…
For reference: MKM · Qingdao Saber Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
Concretely: Homopeptide · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
Concretely: 96.4% · oral semaglutide · BCH. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
Setup, so nobody has to ask: 97.6% · a GLP-1 receptor agonist · HJ. I am trying to build something sustainable rather than something thorough that I will abandon. I…
For reference: GL Biochem · Chinese Peptide Company. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
Numbers first: JEEP · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested…
Conditions: QST · tirzepatide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
This is my second independent submission on material from the same supplier. I want a method I can write down and repeat, not a rule of thumb. I would rather…
This is a first order from this supplier, so I have no track record to reason from. I want to know whether this is a real physical effect or an artefact of how it is…
What I have: JEEP · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date,…
What I am working with: ERP · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched…
For reference: SSA · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The case in front of me: HJ · Zhuhai Kerui Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
The case in front of me: HJ · tirzepatide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
What I have: mazdutide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I can predict the outcome but I cannot explain it, which means I will get the…
What I have: WWB · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date, and…
Conditions: 98.8% · liraglutide · BCH. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down,…
The particulars: QYB · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The particulars: SSA · Qingdao Saber Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…